Health Care: Drugs

Prana Biotechnology Limited (PRAN: NASDAQ)

$2.29 0.01 | 0.43%

05/23/13 - 03:59 PM ET

Company Income Statement

Preferred Dividends
	Jun 2012	Jun 2011	Jun 2010	Jun 2009
Sales	2.59M	166.87K	182.73K	345.57K
Cost of Sales	0.00	0.00	0.00	0.00
Gross Operating Profit	2.59M	166.87K	182.73K	345.57K
Selling, General, and Administrative Expenses	1.78M	4.36M	4.24M	5.22M
Research & Development	4.33M	2.49M	74.78K	1.79M
Operating Income before D & A (EBITDA)	-3.52M	-6.68M	-4.14M	-6.66M
Depreciation & Amortization	20.09K	33.75K	29.99K	27.59K
Interest Income	0.00	0.00	0.00	0.00
Other Income - Net	-1.82M	-157.52K	-5.17K	617.96K
Special Income / Charges	0.00	0.00	0.00	0.00
Total Income Before Interest Expenses (EBIT)	-5.37M	-6.87M	-4.17M	-6.07M
Interest Expense	0.00	0.00	0.00	0.00
Pre-Tax Income	-5.37M	-6.87M	-4.17M	-6.07M
Income Taxes	0.00	0.00	0.00	0.00
Minority Interest	0.00	0.00	0.00	0.00
Net Income From Continuing Operations	-5.37M	-6.87M	-4.17M	-6.07M
Net Income From Discontinued Operations	0.00	0.00	0.00	0.00
Net Income From Total Operations	-5.37M	-6.87M	-4.17M	-6.07M
Extraordinary Income/Losses	0.00	0.00	0.00	0.00
Income From Cum. Effect of Acct. Change	0.00	0.00	0.00	0.00
Income From Tax Loss Carryforward	0.00	0.00	0.00	0.00
Other Gains / Losses	0.00	0.00	0.00	0.00
Total Net Income	-5.37M	-6.87M	-4.17M	-6.07M
Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge)	-5.37M	-6.87M	-4.17M	-6.07M
Net Income Available To Common	-5.37M	-6.87M	-4.17M	-6.07M
Basic EPS from Continuing Ops.	-0.19	-0.28	-0.17	-0.32
Basic EPS from Discontinued Ops.	0.00	0.00	0.00	0.00
Basic EPS from Total Operations	-0.19	-0.28	-0.17	-0.32
Basic EPS from Extraordinary Inc.	0.00	0.00	0.00	0.00
Basic EPS from Cum Effect of Accounting Change	0.00	0.00	0.00	0.00
Basic EPS from Tax Loss Carryf'd.	0.00	0.00	0.00	0.00
Basic EPS from Other Gains (Losses)	0.00	0.00	0.00	0.00
Basic EPS, Total	-0.19	-0.28	-0.17	-0.32
Basic Normalized Net Income/Share	-0.19	-0.28	-0.17	-0.32
EPS fr Continuing Ops.	-0.19	-0.28	-0.17	-0.32
EPS fr Discontinued Ops	0.00	0.00	0.00	0.00
EPS fr Total Ops.	-0.19	-0.28	-0.17	-0.32
EPS fr Extraord. Inc.	0.00	0.00	0.00	0.00
EPS fr Cum Effect of Accounting Change	0.00	0.00	0.00	0.00
EPS fr Tax Loss Carfd.	0.00	0.00	0.00	0.00
EPS fr Other Gains (L)	0.00	0.00	0.00	0.00
EPS, Total	-0.19	-0.28	-0.17	-0.32
Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge)	-0.19	-0.28	-0.17	-0.32
Dividends Paid per Share	0.00	0.00	0.00	0.00